In vivo selection of a lymphocytic choriomeningitis virus variant that affects recognition of the GP33-43 epitope by H-2Db but not H-2Kb

Journal of Virology
M T PuglielliR Ahmed

Abstract

CD8 T cells drive the protective immune response to lymphocytic choriomeningitis virus (LCMV) infection and are thus a determining force in the selection of viral variants. To examine how escape mutations affect the presentation and recognition of overlapping T-cell epitopes, we isolated an LCMV variant that is not recognized by T-cell receptor (TCR)-transgenic H-2Db-restricted LCMV GP33-41-specific cytotoxic T lymphocytes (CTL). The variant virus carried a single-amino-acid substitution (valine to alanine) at position 35 of the viral glycoprotein. This region of the LCMV glycoprotein encodes both the Db-restricted GP33-43 epitope and a second epitope (GP34-42) presented by the Kb molecule. We determined that the V-to-A CTL escape mutant failed to induce a Db GP33-43-specific CTL response and that Db-restricted GP33-43-specific CTL induced by the wild-type LCMV strain were unable to kill target cells infected with the variant LCMV strain. In contrast, the Kb-restricted response was much less affected. We found that the V-to-A substitution severely impaired peptide binding to Db but not to Kb molecules. Strikingly, the V-to-A mutation did not change any of the anchor residues, and the dramatic effect on binding was therefore une...Continue Reading

References

Nov 1, 1995·Journal of Virology·G WeidtF Lehmann-Grube
Apr 1, 1995·Journal of Virology·D Moskophidis, R M Zinkernagel
Jan 1, 1995·Immunogenetics·H G RammenseeS Stevanoviíc
Oct 4, 1996·Science·J D AltmanM M Davis
Aug 1, 1997·Journal of Virology·M F BachmannP S Ohashi
Aug 23, 2000·Immunology Today·A Alcami, U H Koszinowski

❮ Previous
Next ❯

Citations

Mar 3, 2011·Immunologic Research·Lindsay J Edwards, Brian D Evavold
Dec 22, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jennifer D BassettJonathan L Bramson
Aug 24, 2010·The Journal of Biological Chemistry·Zu T ShenLawrence J Stern
Apr 11, 2007·The Journal of Experimental Medicine·Haina ShinE John Wherry
Dec 18, 2008·International Immunology·Georgi S AngelovImmanuel F Luescher
Nov 3, 2004·The Journal of Clinical Investigation·Urs ChristenMatthias G von Herrath
Aug 17, 2012·Immunity & Ageing : I & a·Adam BunztmanJeffrey A Frelinger
Jan 1, 2004·Biological Reviews of the Cambridge Philosophical Society·Kyle SummersHolly Snow
Jul 28, 2016·The Journal of Experimental Medicine·Daniel T UtzschneiderDietmar Zehn
Mar 7, 2020·PLoS Pathogens·Brian M SullivanMichael B A Oldstone
Feb 10, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Frederick J SchnellBrian D Evavold
Mar 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Peter Johannes HolstAllan Randrup Thomsen
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Masha Fridkis-HareliEllis L Reinherz
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lucas Malard VellosoAdnane Achour
Aug 26, 2020·Nature Immunology·Daniel T UtzschneiderAxel Kallies
Jun 10, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christopher C KemballAron E Lukacher
Sep 26, 2019·Frontiers in Immunology·Sujana SivapathamJens V Stein
Mar 28, 2008·Science Signaling·Sarah E HenricksonUlrich H von Andrian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.